Background: Higher rates of alcohol use disorders (AUD) have been observed in some Native American populations than other ethnic groups such as European Americans (EAs) in the United States. Previous studies have shown that variation in the alcohol dehydrogenase (ADH) genes may affect the risk for development of AUD and that the prevalence of these variants differs depending on the ancestral origins of a population.
L ARGE-SCALE epidemiological studies have shown that alcohol use disorders (AUD), as defined by DSM-5 (American Psychiatric Association, 2013) , are highly prevalent in the United States (Grant et al., 2015) . The rates of AUD vary across ethnic groups and populations. Compared to other ethnic groups such as European Americans (EAs) in the United States, the rates of AUD and other drug dependence are among the highest (4 to 5 times of the national average) in some American Indian/Alaska Native (AI/AN) populations and the lowest among some Asian populations (Compton et al., 2007; Grant et al., 2015) . Ethnic differences in the rates of alcohol and other substance dependence are thought to be due to both genetic and environmental factors (Ehlers and Gizer, 2013) .
Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) are the primary enzymes involved in alcohol (ethanol [EtOH] ) metabolism. The main pathway of EtOH metabolism consists of its conversion to acetaldehyde mediated by ADH and subsequent conversion from acetaldehyde to acetate by ALDH. Liver is the primary site of EtOH oxidation. Both enzymes occur in multiple forms that differ in their kinetic properties, and are encoded by different genes. Further, coding variants within these genes have been shown to alter the properties of the enzymes they encode. For example, previous studies have suggested that variants within the ADH and the ALDH genes may affect the risk of development of AUD (Bosron et al., 1993; Chen et al., 2009; Edenberg, 2007) . Indeed, one of the most consistent linkage findings for alcohol dependence contains the ADH gene cluster on chromosome 4q: The region was initially reported in the Collaborative Studies on the Genetics of Alcoholism (COGA) study Reich et al., 1998) and subsequently replicated in different populations including EAs, African Americans, and AIs (Ehlers et al., 2004a; Gizer et al., 2011b; Prescott et al., 2006) .
Variants within these genes, however, may differentially affect the risk for the disorder depending on the ethnic groups being evaluated. For instance, the ADH1B*2 and ADH1B*3 alleles-each resulting in an amino acid changeproduce more efficient enzymes that allow rapid acetaldehyde accumulation (Carr et al., 1989; Hurley et al., 1990) . As a result, ADH1B*2 has shown a protective effect against alcohol dependence in several populations, particularly in East Asians where the allele is found at high frequency (Gelernter et al., 2014; Macgregor et al., 2009; Park et al., 2013; Thomasson et al., 1991 Thomasson et al., , 1994 . Similarly, the ADH1B*3 allele has shown a significant protective effect on risk for alcoholism in certain African American populations Gelernter et al., 2014) . The allele also showed a protective effect in an admixed AI population (Wall et al., 2003) . Other prominent associations between ADH genes and alcohol dependence have been reported for ADH1C in various populations such as East Asian (Higuchi et al., 1995) , European (Kuo et al., 2008) , and AI (Mulligan et al., 2003) and for ADH4 in EA , Australian (Macgregor et al., 2009) , and AI (Gizer et al., 2011a) cohorts. The majority of these studies were based on linkage analysis or candidate genes; a small number resulted from genomewide association studies (Gelernter et al., 2014) .
The advent of genome sequencing technology and analysis methodology has enabled us to investigate common as well as rare genomic variants at high resolution in special populations enriched for AUD phenotypes. The present report is part of a larger study exploring risk factors for substance dependence in an AI community (Ehlers et al., 2004b; Gilder et al., 2004 Gilder et al., , 2008 ) and a nationwide study on genetics of alcoholism and other substance dependence in a primarily EA population (Gizer et al., 2011b; Seaton et al., 2004; Vieten et al., 2004) . We previously evaluated effects of variants in the ADH and ALDH genes on alcohol dependence phenotypes in a subset of the AI cohort and found significant evidence for association with a severity level of alcohol drinking-related dependence symptoms phenotype across the ADH gene cluster (Peng et al., 2014) . Our study also suggested that a higher degree of AI ancestry was associated with higher frequencies of potential risk variants. Following that study, we sequenced the EA cohort and additional AI samples using the same pipeline to allow for direct comparisons of findings across the 2 cohorts.
The aim of this study was 2-fold. The first aim of the study was to assess the influence of common variation in the ADH genomic region (ADH1-7) on AUD phenotypes for the 2 independent populations: AI and EA. We focused on the ADH region in the present work given the previously reported significant results on the ADH genes but little evidence of effects of ALDH variants in the AIs. The AUD phenotypes we investigated include the count of alcohol dependence drinking symptoms and the weighted alcoholrelated life events, both quantifying the level of severity or progression of AUD. To accomplish this aim, a mixed-effect model was used to test for single-variant associations to incorporate admixture and familial relatedness. And a feature selection method was used to select multiple variants in the region that were collectively associated with the phenotypes. The second aim was to assess the influence of rare variation in the ADH genomic region (ADH1-7) on AUD phenotypes for the 2 independent populations. The sequence kernel association test (SKAT) was used for rare-variant analysis.
MATERIALS AND METHODS

Participants and Phenotypes
The protocol of the study of the AI cohort was approved by the Scripps Research Institute Institutional Review Board (IRB) and Indian Health Council, a tribal review group overseeing health issues for the reservations where recruitments took place. The protocol for collection of participants in the San Francisco Family Alcohol Study (SFFS) was approved by the University of California, San Francisco Committee for the Protection of the Rights of Human Subjects while the recruitment took place. Subsequently, the University of North Carolina, at Chapel Hill IRB, approved the data analysis plan. Written informed consent was obtained from each participant after study procedures had been fully explained. Participants were compensated for their time spent in the study.
AI Cohort. A total of 903 AIs from extended pedigrees participated in the study. The population characteristics and the recruitment procedures have been previously described (Ehlers et al., 2011) . A total of 750 individuals had their whole genome sequenced.
San Francisco Family Alcohol Study. The San Francisco Family Alcohol Study (SFFS) was a nationwide genetic study on alcoholism and other substance dependence. The recruitment process and the population characteristics have been previously described (Gizer et al., 2011b; Seaton et al., 2004; Vieten et al., 2004) . A total of 2,524 individuals participated in the study. A total of 1,889 subjects had their whole genome sequenced.
All participants were assessed using the Semi-Structured Assessment for the Genetics of Alcoholism (SSAGA) (Bucholz et al., 1994; Hesselbrock et al., 1999; Wall et al., 2003) in order to collect demographic information and to make DSM-IV and DSM-5 diagnoses (American Psychiatric Association, 2013; American Psychiatric Association Task Force on DSM-IV, 1994). After quality control and missing data removal, 742 participants from the AI cohort and 1,215 participants from the SFFS cohort remained for further analysis in this study. Their demographics are listed in Table 1 .
Two phenotypes were studied: a count variable corresponding to the presence or absence of a subset of 4 DSM-IV alcohol dependence symptoms related to drinking severity; and the sum of weighted alcohol-related life events derived from 36 items measuring the clinical course of alcohol dependence. The number of DSM-IV alcohol dependence symptoms related to drinking included the following: (i) drank more than intended/more days in a row or when promised self wouldn't for 3 or more times; (ii) drunk when didn't want to 3 or more times; (iii) had little time for anything else during drinking or recovering from the effects of drinking; and (iv) given up or greatly reduced important activities to drink (Ehlers et al., 2004c) . Scores on this DSM-IV alcohol dependence-based drinking severity index ranged from 0 to 4. The weighted alcohol-related life events phenotype was derived from 36 alcohol clinical course items of DSM-5 AUD (Ehlers et al., 2015) . The 36 items are listed in Table 2 and ordered by the mean age of occurrence for each event.
The alcohol life events were given a severity weight of 1 for items 1 to 12, 2 for 13 to 24, and 3 for 25 to 36 such that events that typically happen later in life are weighted higher. The phenotype is defined as the sum of the severity weights of the 36 alcohol-related life events. It is a new metric reflecting the severity and progression of AUD. The statistical characteristics of the 2 phenotypes are listed in Table S1 for the 2 cohorts.
Sequencing and Variants Calling
The same methods and pipeline were used to sequence the AI and the SFFS cohorts and have been previously published . In brief, blood derived DNA was sequenced using Illumina (San Diego, CA) low-coverage whole genome sequencing (WGS). Reads from WGS were aligned to GRCh37/hg19 human reference genome using BWA and realigned near indels with GATK (DePristo et al., 2011) . Variants were called using both GATK Unified Genotyper following the best practices for low-coverage samples (Van der Auwera et al., 2013) , and imputation was carried out using the linkage disequilibrium (LD)-aware variant caller Thunder . The variants for each cohort were called separately.
Candidate Genomic Region
We tested for associations between AUD phenotypes and variants across the genomic regions around the ADH genes. The sequence map coordinates for the analyzed region on chromosome 4 include the ADH gene cluster region ADH7-ADH1C-ADH1B-ADH1A-ADH6-ADH4-ADH5, and the flanking 10,000 base pairs (bp) were 99,982,130 to 100,366,894. The region had 3,529 single nucleotide variations (SNVs) called for the AI cohort and 5,020 SNVs for the EA cohort. There were 1,657 and 1,640 variants with at least 1% minor allele frequency (MAF) for AIs and EAs, respectively.
ADH Region Single-Variant Association Analysis
While SFFS cohort is primarily composed of EAs, most AI participants have an admixed ancestral background (Norden-Krichmar et al., 2014; Peng et al., 2014) . Additionally, both cohorts have family structures. A linear mixed model as implemented in EMMAX (Kang et al., 2010) was used for single-variant association analysis to incorporate both population structures and familial relatedness. Age, age-squared, and sex were included as covariates in all analyses. We also tested differential effects of the resulting associations between the 2 cohorts using a 2-sample Z-test (Cohen et al., 2003) . Full details are given in Appendix S1.
Multiple-Testing Adjustments
Many variants in the candidate ADH regions are in LD, or in other words, correlated, especially given that genomic sequencing data were used. In addition, the AUD phenotypes are also correlated. A simple Bonferroni correction would thus be overly conservative. To correct for multiple comparisons, we first computed the effective number of independent variants (M eff ) using a principal component approach as implemented in simpleM (Gao et al., 2010) . We then obtained the effective number of independent traits (Nyholt, 2004) . Because we were interested in identifying variants in the ADH region that might potentially have functional effects on any of the AUD phenotypes, we adopted a hierarchical testing approach for error control . Briefly, the association tests performed on each variant are treated as a family of hypotheses; for each variant, a p-value is obtained for the intersection of individual hypotheses. False discovery rate (FDR) adjustment (referred to as vFDR) is then applied to the collection of the pvalues with an FDR target error rate q 1 . Once a set of variants is selected, within the family of each selected variant, the FDR procedure with adjustment for selection bias (referred to as sFDR) is applied to test individual hypotheses with a target level q 2 . At each stage of the testing procedure, we used the M eff -based FDR procedure (Li and Ji, 2005) . We report results for q 1 = q 2 = 0.1. For single-variant association analyses, we included all variants with MAF over 1% in either cohort and derive M eff from these variants. Of 1,657 and 1,640 total variants for the Native American and EA cohorts, the effective number of independent variants turned out to be 358 and 425, respectively. The effective number of independent traits, computed over the phenotypes residualized over covariates, is 1.32 and 1.35 for AIs and EAs.
Variant Selections and Multiple-Variant Association
As many variants in the ADH region are correlated, their effects are in general not independent from each other. Moreover, while single-variant association tests may be effective in identifying individual variants having relatively large effects, variants that individually have smaller effects yet collectively might contribute to the phenotypic variance can easily go undetected. One way to model collective associations from many variants is through multiple regression. Given the much larger number of variants relative to the number of samples, we need to regularize the regression to reduce the number of predictors. Because we were primarily interested in finding a subset of ADH variants that were most associated with AUD phenotypes, we used generalized least squares with lasso on variants across the whole ADH region (Tibshirani, 1994) . Ten rounds of 10-fold cross-validation were used to select the penalty parameter k for each phenotype and cohort.
Liver eQTL Analysis and Functional Predictions
Liver-specific cis-eQTL data were obtained from the Genotype-Tissue Expression (GTEx) Project version V6p (Aguet et al., 2016) . Only ADH genes were considered. In addition to the significant variants from the association analysis, the single nucleotide polymorphisms (SNPs) in LD with the significant variants were also examined. The threshold for LD was D 0 ≥ 0.5 and R 2 ≥ 0.1 (a low R 2 threshold allows for large allele frequency differences between variants). If a variant resides within an exon of a gene, PolyPhen-2 was used to assess the potential functional impact of the variant (Adzhubei et al., 2010) .
Rare-Variant Association Analysis
The SKAT (Wu et al., 2011) implemented within a linear mixed model was used for rare-variant tests of association. We tested for each genes separately and also for the entire region. For each ADH gene, we included all its rare variants (MAF ≤ 1%). For the region, we included all rare variants in the ADH region with MAF ≤ 1%.
As not all variants in this region are potentially causal and effects may be in either direction, SKAT that uses a multiple regression model is presumably more powerful than other burden tests. The kernel function was the default beta distribution density function b (1,25). For gene-based rare-variant test, we assumed that the 7 genes were independent and used the same hierarchical testing approach described above to correct for multiple comparisons.
Full details are given in Appendix S1: Materials and Methods.
RESULTS
No variant in the ADH region was significantly associated with either of the 2 AUD related phenotypes for the EA SFFS cohort (see Table 3 ). For the AIs, variant rs187709743, 3.7-kb downstream of ADH4, is the top variant in the ADH region that was associated with both the alcohol-related life events and the alcohol dependence drinking symptoms phenotypes (variant discovery vFDR = 0.003, see Fig. 1 to visualize the variant locations, and Fig. S1 for LocusZoom plots). At slightly less significant levels, variant rs116822782 upstream of ADH4 is also associated with both phenotypes. Two additional variants, downstream and upstream of ADH1C, respectively, are only significantly associated with the alcoholrelated life events (Table 3 and Fig. 1 ). As described in the Methods section, the FDRs were obtained by a hierarchical approach adjusting the nominal p-values using M eff -based FDR procedures at each stage. All significant association effects for AIs are positive, indicating that the variants are potentially risk alleles. Note that with the exception of the rare-variant rs116822782 whose allele frequency is around 1% in both cohorts, the other 3 SNPs all have much higher allele frequencies in AIs than in EAs. Of the 2 top variants, rs187709743 and rs55960155, while they both are rather common in the AIs (MAF = 14.8%, 8.4% respectively), the former is rare (MAF = 0.7%) and the latter absent in the EAs.
Because none of the significant findings were within the genes themselves, to investigate whether these variants might confer any functional effects, we examined the liver-specific cis-eQTLs effects of the ADH genes and the significant variants or those in LD with them. The top SNP-gene associations are listed in Table S2 . Of the 4 variants that were associated with AUD in AI (Table 3) , the most significant liver eQTL was found on SNPs that are in LD with rs187709743 (D 0 = 1, R 2 = 0.15 to 0.29) for genes ADH5 and ADH4 (Table S2) . Additionally, SNPs in LD with rs55960155 (D 0 = 0.98 to 1, R 2 = 0.12 to 0.13) were most significantly associated with ADH1C expression in liver.
The results of differential association analysis between the 2 cohorts are described in the Supplemental Results (Appendix S2) and listed in Tables S4 and S5 .
Using the regularized multiple regression analysis, 37 variants in the ADH region were selected in AI for the alcohol-related life events phenotype (p-value = 1.1 9 10 À11 for multiple regression using selected variants) and 33 for the alcohol dependence drinking symptoms (p = 5.8 9 10 À10 ), of which 13 were shared. In the EA cohort, 20 variants (p = 4.8 9 10
À8
) and 21 variants (p = 5.7 9 10 À10 ) were selected for the 2 phenotypes, respectively, of which 8 were shared (see Fig. 1 and Table S3 ). Note that the p-values reported here were biased because variants were already selected for relevance. Only 2 variants were selected in both cohorts: a new variant chr4:100068799 at 3,350-bp upstream of ADH4 and chr4:100092848 (rs60239449) at intergenic region between ADH4 and ADH6. Of variants selected in the AI cohort, 11 were absent from the EA cohort, of which 4 were common (MAF ≥ 5%) in the AIs; of those selected in the EAs, 1 variant was absent from the AIs. Three out of the 26 (30%) variants selected that were located within the genes were on exons.
We further conducted rare-variant analysis. For genebased tests (see Table S6 ), ADH5 was the most significant (nominal p = 0.027) for alcohol-related life events in AI, and ADH4 was the most significant for alcohol dependence drinking symptoms for both cohorts (nominal p = 0.081 for AIs, 0.047 for SFFS). However, no gene remained significant after multiple-testing corrections. Because all of the observed significant single-variant associations and the majority of the selected variants (70%) in the 2 cohorts were either upstream or downstream from an ADH gene or in the intergenic regions, we did another test that included all rare variants with MAF ≤ 1% across the entire ADH region. There were 1,865 and 3,043 rare variants for AIs and SFFS, respectively. Nearly all participants had some rare variants in the region. That SFFS EA cohort had many more rare variants in the region is likely due to its larger sample size. The only association with a nominal p-value less than 0.05 (p = 0.043) was observed for the alcohol-related life events in AIs. Once corrected for multiple traits, its FDR is 0.057 (Table 4) .
DISCUSSION
The primary aims of this study were to assess common and rare genomic variations in the chromosomal region containing the 7 ADH genes (ADH7-ADH1C-ADH1B-ADH1A-ADH6-ADH4-ADH5) that encode the primary alcohol metabolic enzyme family in an AI and an EA population Table 3 ). and to test their associations with alcohol use disorder AUD symptomatology. We conducted single-variant, multivariant, and rare-variant association analyses on the number of alcohol dependence drinking symptoms and weighted alcoholrelated life events. Four ADH variants were significantly associated with the alcohol-related life events phenotype in AIs, while no variant was significantly associated with either phenotype in EAs. They are upstream or downstream of ADH4 and ADH1C. The 2 variants near ADH4 were also significantly associated with the alcohol dependence drinking symptoms. Of note, the most significant variant, rs187709743, is common in AIs at near 15% MAF but rare in EAs with 0.7% MAF. Although there was no direct eQTL data available for the significant variants, those in strong LD with rs187709743 exhibited cis-eQTL signals for ADH4 and ADH5 in the liver (Table S2 ). It appears that the haplotypes containing the minor allele of rs187709743 may increase the expression of ADH5 and decrease the expression of ADH4. ADH5 is expressed in most tissues and encodes v-ADH that has very low affinity for EtOH. Its effects on the risk for AUD, however, are unclear. ADH4 is expressed primarily in the liver and the cornea and encodes p-ADH that contributes to EtOH oxidation at high or moderate concentrations. Variants in ADH4 and in the intergenic region between ADH4 and ADH5 have been found to be associated with alcohol dependence in the COGA cohort, which is mainly comprised of EAs and African Americans, using the pedigree disequilibrium test and in another EA population using structured association tests (Luo et al., 2005b) . Of the 12 significant SNPs in Edenberg and colleagues (2006) and 3 significant SNPs in Luo and colleagues (2005b) , 14 were in our cohorts. All 14 variants are in LD with rs187709743 (D 0 = 1, R 2 varies and is small in general due to allele frequency differences) in AIs, and the minor allele of rs187709743 is on the same haplotypes with the major alleles of these variants with the exception of rs4148886 (MAF = 44%). In addition, the minor allele of variant rs3762894 has been reported to be protective against alcohol withdrawal in the same AI population (Gizer et al., 2011a) . In the present AI cohort, rs187709743 and rs3762894 (MAF = 11%) are in LD (D 0 = 1), and the minor allele of rs187709743 and the major allele of rs3762894 are on the same haplotypes. This evidence consistently suggests that haplotypes containing the minor allele of rs187709743 might confer risk for AUD by reducing the expression level of ADH4 in liver, which might potentially slow down the oxidation of EtOH (and the accumulation of acetaldehyde) at high concentrations, thus mitigating the adverse effect of acetaldehyde. These effects are likely unique to admixed AI populations, as rs187709743 is rare in the EA cohort and in general rare or absent in all but admixed American (AMR, MAF = 11%) populations in the 1000 Genome database (Siva, 2008) .
Variant rs55960155 is common (MAF = 8.4%) in the AI cohort and absent from the EA samples altogether. Variants in strong LD with rs55960155 showed eQTL signals for ADH1C and ADH6 in liver (Table S2 ). It appears that haplotypes containing the minor allele of rs55960155 may decrease the expression level of ADH1C and increase that of ADH6. While not much is known about the functional aspect of ADH6, there is substantial evidence suggesting that the ADH1C*1 allele is protective against alcohol dependence in populations such as East Asian (Higuchi et al., 1995; Matsushita and Higuchi, 2017; Thomasson et al., 1991 Thomasson et al., , 1994 , European (Kuo et al., 2008) , and AI (Mulligan et al., 2003) although the effect may be due to the LD between ADH1C*1 and ADH1B*2. In addition, ADH1C*2 was shown to increase the risk for alcoholism in a Mexican American sample (Konishi et al., 2003) . In this AI cohort, the minor allele of rs55960155 appears on the same haplotypes with ADH1C*2 (AF = 41%) and ADH1B*1 (AF = 91%) alleles, although neither ADH1C*2 nor ADH1B*1 is a significant risk allele in AI (nominal p-values were between 0.025 and 0.030 and were not significant after correction for multiple comparisons). There was additional evidence to suggest that ADH1C gene expression differed by 2-fold between various haplotypes in a region located from 3,496-to 3,008-bp upstream of the transcription start site of the gene (Chen et al., 2005) , and rs55960155 is in this region, being 3,120-bp upstream of ADH1C. Taken together, it suggests that haplotypes containing the minor allele of rs55960155 might increase the risk for AUD in AIs by reducing the gene expression of ADH1C in liver. The most significant variants for the EA cohort were in or near ADH7, but none remained significant once corrected for multiple comparisons (Table 3) .
In addition to the single-variant results, 57 and 33 genomic variants across the ADH gene cluster region were selected in the AI and the EA cohorts, respectively, to be associated with at least one of the AUD phenotypes through regularized multivariant regressions ( Fig. 1 and Table S3 ). Two of the top variants around ADH4 in the single-variant association tests were also in the selected subset in AI. The 2 top variants in and near ADH7, although not significant in the single-variant association tests for EA, were in the selected subset for EA. Although most of the selected variants in EA were colocated in the same regions with those in AI, all but 2 variants were distinct to the respective cohorts. That only 3 variants reside within exons suggest that the potential functional impacts of most of the associated variants are regulatory. Of the 3 exonic variants, rs6413444 on ADH1C is synonymous and associated with alcohol-related life events in EAs. The other 2 are nonsynonymous: rs1229984 was associated with both phenotypes in AIs and rs1573496 with alcohol-related life events in AIs. Notice that the A allele of variant rs1229984 corresponds to the ADH1B*2 allele that is protective against AUD in East Asian populations. The allele frequency of this protective variant, however, was only 4% and 1% in the AI and the EA cohorts, respectively. Variant rs1573496 is located in an exon of ADH7 and predicted by PolyPhen-2 to be probably damaging with a probability score of 0.973. Of note, variant rs1800759 in the promoter region of ADH4 Luo et al., 2005a) was selected in association with alcohol-related life events in EAs. Overall, largely distinct subsets of variants were selected for AIs and EAs, respectively, although some of them were in the same regions.
EtOH is primarily oxidized in liver. Given the ADH enzyme concentrations and properties in liver, it has been theorized that the class I enzymes encoded by ADH1A/B/C and class II enzyme encoded by ADH4 contribute the most to alcohol metabolism (Hurley et al., 2002) . Apart from the well-known ADH1B alleles that have different frequencies in different ancestral populations resulting in protection effects against alcoholism in populations such as East Asian and African, the other ADH genes that are found more prominently associated with AUD are ADH4 and ADH1C. These are consistent with our findings. In association studies across populations and cohorts, the desire is often to identify variants shared by different samples that contribute to a phenotype, either through replication or by combining the cohorts directly, or indirectly through meta-analysis. The increased statistical power gained by these approaches aid in the discovery process. It is, however, equally important to determine how genomic variations may differentially affect populations. The differential effects not only provide insights into risk or protection for the disorders across ethnic groups but may also have potential clinical relevance. Moreover, for admixed populations such as AIs, alleles from different ancestral backgrounds might come together to affect risk. Indeed, we have identified variants that are either unique or more common in AIs than in the EAs that might confer further risk for AUD by potentially reducing the levels of the 2 most relevant classes of ADH enzymes. All of the variants we identified in the single-variant associations are upstream or downstream from a gene or in the intergenic regions, implying their potential involvement in regulatory functions, which is also consistent with our findings in the multivariant associations. Although they are in LD with variants in the coding regions, those variants themselves did not exhibit significant individual associations with the AUD phenotypes in either AIs or EAs.
There are several limitations to our study. These cohorts do not represent all AIs or all EAs as both samples were not ascertained using random sampling techniques. The AI cohort is a community sample. The EA cohort is comprised of semi-targeted recruits who met certain screening criteria for alcohol dependence and a smaller set of unselected general population sample with similar demographics (Gizer et al., 2011b) . As a result, the 2 cohorts have a large mean age difference (Table 1 ) and the EA cohort has on average higher numbers of alcohol-related life events and alcohol dependence drinking symptoms (Table S1 ). These differences could have potentially influenced the study results, even though age and age-squared were included as covariates, and with quantitative traits, there is no need to adjust for prevalence with linear regressions. There might also be a potential violation of the homoskedasticity assumption. The sample sizes were moderate in both cohorts relative to the number of variants we tested, even after taking variant correlations into consideration. Although we used the effective number of independent variants in multiple-testing corrections, the computation was based on correlations between variants that are usually low when variants are of rather different frequencies. Thus, their actual independence is somewhat obscured. This might explain why no association remained significant in the single-variant analysis for the EA cohort even though previous works have reported significant relations between individual ADH variants and alcoholism in EA samples; nonetheless, those studies were either based on linkage analysis or using a relatively small number of genotyped variants. Similarly, the number of significant variants in ADH was also much fewer than our previous work in AIs, although many of the variants are in LD with each other. Additionally, because many variants in the ADH region are in high LD, it is difficult to infer the actual causal variants with respect to AUD.
Limitations notwithstanding, the present study has identified individual ADH variants that might confer risk for alcohol-related symptomatology in AIs but not for EAs. These variants are either unique to the AIs or more common in the AIs than in the EAs. When ADH variants were considered collectively, largely distinct subsets of common and less frequent variants were selected for AIs and EAs, respectively, yet many of them colocated with each other in the same regions. The rare variants across ADH on the other hand seem to contribute to alcohol symptomatology in AIs but not in EAs. Our results suggest that ADH variants, both common and rare, are more likely to impact risk for alcohol-related symptomatology in this AI population than in this EA sample, and variants that might affect AUD are likely different although often convergent onto the same genomic regions between the 2 populations. We remark, however, that ADH variants only explain a small fraction of the potential genetic contribution to alcohol symptomatology. Further, overall genetic variance can only explain part of the AUD variations. Unmeasured risk factors, some specific to AIs/ANs or to EAs, could also potentially explain some of the relationship between AUD and ADH variants.
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